BioReperia Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Grant
  • (Announced)
  • Investors
  • 6

BioReperia General Information


Developer of a zebrafish technology platform designed to accelerate the process of drug discovery. The company offers zebrafish tumor xenograft models in which patients' tumor cells are implanted into zebrafish embryos in order to predict the most effective cancer treatment and facilitate identification of drug actions and toxicity, enabling pharmaceutical companies to increase precision reliability and the speed of pre-clinical development with increased success rate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • C/O LEAD företagsinkubator
  • Teknikringen 7, v.2
  • 583 30 Linköping
  • Sweden
+46 079-332 00 00

BioReperia Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioReperia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Mar-2019 00.000 Announced Generating Revenue/Not Profitable
4. Early Stage VC 22-May-2019 00000 00.000 Completed Generating Revenue/Not Profitable
3. Grant 05-Oct-2017 00000 00000 Completed Generating Revenue/Not Profitable
2. Early Stage VC 29-Jun-2017 $230K $230K Completed Generating Revenue/Not Profitable
1. Accelerator/Incubator Completed Startup

BioReperia Executive Team (5)

Name Title Board Seat Contact Info
Anna Fahlgren Co-Founder, Chief Executive Officer & Board Member
Anna Nilsson Ph.D Chief Operating Officer
Lasse Jensen Ph.D Co-Founder, Chief Technology Officer & Board Member
Malin Vildevall Ph.D Chief Scientific Officer

1 Former Executive

BioReperia Board Members (1)

Name Representing Role Since
Henrik Lewander Self Board Member 000 0000

BioReperia Investors (6)

To view BioReperia‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almi Invest Venture Capital Minority 000 0000 000000 0
HEMEX AG Corporate Development Minority 000 0000 000000 0
LEAD Incubator Accelerator/Incubator Minority 000 0000 000000 0
Linköping University Other Minority 000 0000 000000 0
SWElife Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial